Home SpiroConnect Where to Buy Manuals Certificates Privacy Policy ATS/ERS 2019 Updates MedChip Solutions Covid-19 Response Contact Us
Home SpiroConnect Where to Buy Manuals Certificates Contact Us ATS/ERS 2019 Updates Covid-19

Technological innovations for respiratory diagnostics

SpiroConnect® - COPD

COPD – Definition

COPD Lung Image

"Chronic Obstructive Pulmonary Disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that is usually progressive and associated with enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients."1

"Worldwide, COPD was ranked as the sixth leading cause of death in 1990. It is projected to become the fourth leading cause of death worldwide by 2030, due to an increase in smoking rates and demographic changes in many countries."2

"COPD is one of the most common respiratory diseases in the UK causing about 25,000 deaths a year. It usually affects people over the age of 35, although most people are not diagnosed until they are in their fifties. It is thought there are over 3 million people living with the disease in the UK, of which only about 900,000 have been diagnosed."3

It is important that COPD is diagnosed as early as possible so treatment can be used to try to slow down the deterioration of the lungs.

The Standards for the Diagnosis and Treatment of Patients with COPD document 2004 updates the position papers on chronic obstructive pulmonary disease (COPD) published in 1995."4,5

In clinical practice, COPD is defined by its characteristically low airflow on lung function tests. In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time. www.brit-thoracic.org.uk

With its precision transducer and low-flow sensitivity the SpiroConnect® is accurate even in the most severe COPD patients. This enables clinicians to make an accurate diagnosis and improve patient care.

As a part of the remote home monitoring system SpiroConnect® may also improve the disease management leading to reduction and early recognition of exacerbation of COPD resulting in improving patient's quality of life and reduction in hospitalization.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Website

2. PLOS Medicine Website

3. National Health Service (NHS) Website

4. American Thoracic Society (ATS) Website

5. European Respiratory Society (ERS) Website